E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation

Research output: Contribution to journalArticle

Authors

External Institution(s)

  • University of Louisville

Details

Original languageEnglish (US)
Article number28
JournalBasic research in cardiology
Volume114
Issue number4
StatusPublished - Jul 1 2019
Peer-reviewedYes

Abstract

Several post-translational modifications figure prominently in ventricular remodeling. The beta-O-linkage of N-acetylglucosamine (O-GlcNAc) to proteins has emerged as an important signal in the cardiovascular system. Although there are limited insights about the regulation of the biosynthetic pathway that gives rise to the O-GlcNAc post-translational modification, much remains to be elucidated regarding the enzymes, such as O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), which regulate the presence/absence of O-GlcNAcylation. Recently, we showed that the transcription factor, E2F1, could negatively regulate OGT and OGA expression in vitro. The present study sought to determine whether E2f1 deletion would improve post-infarct ventricular function by de-repressing expression of OGT and OGA. Male and female mice were subjected to non-reperfused myocardial infarction (MI) and followed for 1 or 4 week. MI significantly increased E2F1 expression. Deletion of E2f1 alone was not sufficient to alter OGT or OGA expression in a naïve setting. Cardiac dysfunction was significantly attenuated at 1-week post-MI in E2f1-ablated mice. During chronic heart failure, E2f1 deletion also attenuated cardiac dysfunction. Despite the improvement in function, OGT and OGA expression was not normalized and protein O-GlcNAcyltion was not changed at 1-week post-MI. OGA expression was significantly upregulated at 4-week post-MI but overall protein O-GlcNAcylation was not changed. As an alternative explanation, we also performed guided transcriptional profiling of predicted targets of E2F1, which indicated potential differences in cardiac metabolism, angiogenesis, and apoptosis. E2f1 ablation increased heart size and preserved remote zone capillary density at 1-week post-MI. During chronic heart failure, cardiomyocytes in the remote zone of E2f1-deleted hearts were larger than wildtype. These data indicate that, overall, E2f1 exerts a deleterious effect on ventricular remodeling. Thus, E2f1 deletion improves ventricular remodeling with limited impact on enzymes regulating O-GlcNAcylation.

    Research areas

  • Glycosylation, Heart failure, Hexosamine biosynthetic pathway, Metabolism

Citation formats

APA

Harvard

Dassanayaka, S, Brittian, KR, Jurkovic, A, Higgins, LA, Audam, TN, Long, BW, Harrison, LT, Militello, G, Riggs, DW, Chitre, MG, Uchida, S, Muthusamy, S, Gumpert, AM & Jones, SP 2019, 'E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation', Basic research in cardiology, vol. 114, no. 4, 28. https://doi.org/10.1007/s00395-019-0737-y